Background: Androgenetic alopecia (AGA) is a common cause of hair loss in men with limited treatment options. Platelet-rich plasma (PRP) therapy is one of the newer treatment modalities in the management of AGA with promising results.
Aim: The aim is to assess the efficacy of PRP in males with AGA and to study any adverse events associated with the procedure.